Liuling Xiao, PhD
Luiling graduated from Fudan University, Shanghai, China in 2017, and started the postdoctoral fellow training from September, 2017. My present project focuses on exploring the role of CD8+ T cells in the melanoma and multiple myeloma
Miao Xian, PhD
Miao Xian received her PhD in tumor pharmacology at Zhejiang University where she studied treatment of osteosarcoma and post translational modification of proteins. She joined Yi Lab in October 2019, working on tumor biology of multiple myeloma. Her research focuses on the role of bone marrow microenvironment in multiple myeloma. Miao enjoys go to concerts and music festivals in her free time.
Chuanchao Zhang, PhD
Chuanchao Zhang received his PhD degree in Beijing institute of Genomics, Chinese Academy of Science. He previously worked on DNA damage response, long non-coding RNAs and small peptides. He is well trained in molecular and cell biology and proficient in systematic analysis pipeline for high-throughput sequencing data, including RNA-seq, Chip-seq, PAR-CLIP-seq, etc. His current project focus is on the regulation of multiple myeloma and intrigued by tumor immunity, such as CAR-T. Looking forward to participating in related work in the future.
Yabo Li, PhD
Yabo Li received a joint PhD program at the College of Life Science in Lanzhou University (China) and the Lerner Research Institute in Cleveland Clinic (Ohio, USA). She joined the Yi lab in October 2022. She is interested in transcription factors regulating multiple myeloma (MM) cell proliferation and apoptosis. She’s using cell culture combined with in vivo mouse models to test some new compounds that target MM cells. Her current research is focused on regulation of myeloma drug resistance and targeted treatment in human MM. Yabo enjoys doing flower arrangement and painting when she is not hitting the lab bench or spending time with family and friends.